|
| |
4 |
|
Drug Stocks Up As Osi Rejects $3.5 Billion Bid |
| NEW YORK MarketWatch -- Medical-treatment stocks, including Boston Scientific Corp. and Amylin Pharmaceuticals, made sharp moves on Monday as investors reacted to a spate of regulatory news and as O..... |
|
SingaporeStar -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
3 |
|
Amylin, Alkermes Gain As Fda Needs No New Byetta Data |
| March 15 Bloomberg -- Amylin Pharmaceuticals Inc. and Alkermes Inc. reached their highest levels in 18 months in Nasdaq trading after U.S. regulators said they didnampacircamp#128amp#153t need more studies... |
|
SingaporeStar -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
4 |
|
Making a virtue of patients |
| A new project to tackle bureaucracy in drugs trials hopes to reverse the UKamp#39s decline as a centre of pharmaceutical developmen... |
|
FinancialTimes -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
9 |
|
Submit Photo Write to Journalist/Editor |
| |
| |
2 |
|
Submit Photo Write to Journalist/Editor |
|
| |
| |
10 |
|
Ranbaxy settles Actos patent litigation |
| Ranbaxy Laboratories today said that it has settled its Actos patent litigation with Japanamp#39s Takeda Pharmaceutical company... |
|
BusinessStandard -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
8 |
|
For Novartis, AH1N1 just what the doctor ordered |
| The China division of Novartis Pharmaceuticals saw 36 percent growth in sales last year, contributing to the groupamp#39s overall 11 percent increase in net sales, which rose to $44.3 billion last year.... |
|
EnglishPeople.com -
0000-03-00 00:00:00 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
9 |
|
Holes in cap on sops for doctors |
| New Delhi, March 13: Indiaamp#39s apex medical regulator has specified penalties for doctors who accept cash, gifts, travel or hospitality from pharmaceutical companies. But any incentive below Rs 1,000... |
|
TheTelegraph(Calcutta,India) -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
3 |
|
Sanofi joins Merck in animal health venture |
| The pharmaceutical group has agreed a deal to establish a joint venture with Merck which will be the worldamp#39s largest animal health busines... |
|
FinancialTimes -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
2 |
|
Tech Minute: Beware The Botnet On Your PC |
| More than 2,000 major companies like Paramount Pictures and pharmaceutical giant Merck have been hacked, and your computer might have helped the criminals break in. Increasingly hackers are using so-called... |
|
CBS5 -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
|
| |
| |
5 |
|
Amylin Pharmaceuticals Has Spiked To The Downside |
| Amylin Pharmaceuticals AMLN dipped in early trade Friday, before settling into a range. The stock has fallen sharply in the last few minutes on increased volume and is now down 2.31 at $18.88... |
|
RTTNews -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
10 |
|
Endo Names Ex-nora Therapeutics Ceo As Coo |
| Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer. The company said McHugh will assume her new role on Monday. End..... |
|
SingaporeStar -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
5 |
|
Citi Downgrades Abbott Labs On Profit Worries |
| ABT Friday to sell from hold, citing profitability issues in 2010. Citi said the companyamp#39s recent purchase of Solvay Pharmaceuticals is masking the problems at the drug company. Abbottamp#39s research..... |
|
SingaporeStar -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
7 |
|
Sanofi and Merck to combine animal divisions |
| French and US pharmaceutical groups agree to join their animal health operations, creating a joint venture with nearly $5.3bn in annual sales... |
|
FinancialTimes -
33 minutes ago
|
|
Submit Photo Write to Journalist/Editor |
| |
| |
4 |
|
Submit Photo Write to Journalist/Editor |
|
| |